Stutz, M. D., Ojaimi, S., Ebert, G., & Pellegrini, M. (2018). Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection? Front Immunol.
Chicago-стиль цитированияStutz, Michael D., Samar Ojaimi, Gregor Ebert, and Marc Pellegrini. "Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium Tuberculosis Infection?" Front Immunol 2018.
MLA-цитированиеStutz, Michael D., Samar Ojaimi, Gregor Ebert, and Marc Pellegrini. "Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium Tuberculosis Infection?" Front Immunol 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.